Bridgeway Capital Management, LLC Annovis Bio, Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.76 Billion
- Q1 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Annovis Bio, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 33,600 shares of ANVS stock, worth $186,816. This represents 0.01% of its overall portfolio holdings.
Number of Shares
33,600
Previous 23,600
42.37%
Holding current value
$186,816
Previous $441,000
9.52%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ANVS
# of Institutions
52Shares Held
1.2MCall Options Held
779KPut Options Held
1.77M-
Vanguard Group Inc Valley Forge, PA358KShares$1.99 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA250KShares$1.39 Million0.01% of portfolio
-
Black Rock Inc. New York, NY97.6KShares$542,8170.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA72.6KShares$403,6670.0% of portfolio
-
Geode Capital Management, LLC Boston, MA70.8KShares$393,5970.0% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $45.4M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...